Healing of peptic ulcer by eradicating Helicobacter pylori: Is one week's treatment adequate?;ULCUSHEILUNG DURCH HELICOBACTER-PYLORI-ERADIKATION: GENUGT EINE WOCHE THERAPIE?

Deutsche Medizinische Wochenschrift

Volumn 121, Issue 1-2, 1996, Pages 3-7

  Labenz, J ^a   Tillenburg, B ^a   Peitz, U ^a   Kohl H ^a   Becker, T ^b   Stolte, M ^c   Borsch G ^a  

^a Med Klin Kathol Klin Ruhrhalb   (Germany)

^b ELISABETH KRANKENHAUS ESSEN   (Germany)

^c INSTITUTE OF PATHOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE; TETRACYCLINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER;

EID: 0030059321     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1042964     Document Type: Article

References (16)

1. Axon, A. T. R.: The role of acid inhibition in the treatment of Helicobacter pylori infection. Scand. J. Gastroenterol. 29, Suppl. 201 (1994), 16-23.
2. Bazzoli, F., R. M. Zagari, S. Fossi, P. Pozzato, A. Roda, E. Roda: Efficacy and tolerability of a short-term, low-dose triple therapy for eradication of Helicobacter pylori. Gastroenterology 104 (1993), A140.
3. De Boer, W. A., W. M. M. Driessen, H. V. P.J. Potters, G. N. J. Tytgat: Randomized study comparing 1 with 2 weeks quadruple therapy for eradicating Helicobacter pylori. Amer. J. Gastroenterol. 89 (1994), 1993-1997.
4. Goddard, A., R. Logan: One-week low-dose triple therapy. New standards for Helicobacter pylori treatment. Europ. J. Gastroenterol. Hepatol. 7 (1995), 1-3.
5. Hosking, S. W., T. K. W. Lin, S. C. S. Chung, M. Y. Yung, A. F. B. Cheng, J. J. Y. Sung, A. K. C. Li: Duodenal ulcer healing by eradication of Helicobacter pylori without antiacid treatment. Randomised controlled trial. Lancet 343 (1994), 508-510.
6. Labenz, J., G. Börsch: Klinik und Diagnostik der Helicobacter-pylori-Infektion. Dtsch. med. Wschr. 119 ( 1994), 669-672.
7. Labenz, J., G. Börsch: Therapie der Helicobacter-pylori-Infektion. Dtsch. med. Wschr. 119 (1994), 633-636.
8. Labenz, J., G. Börsch: Towards an optimal treatment of Helicobacter pylori-positive peptic ulcers. Amer. J. Gastroenterol. 90 (1995), 692-694.
9. Labenz, J., M. Stolte, S. Aygen, O. Hennemann, J. Bertrams, G. Börsch: Qualitative und semiquantitative invasive und nicht-invasive Diagnostik der Helicobacter-pylori-Kolonisation der gastralen Mucosa. Z. Gastroenterol. 31 (1993), 437-443.
10. Labenz, J., M. Stolte, G. H. Rühl, T. Becker, B. Tillenburg, M. Sollböhmer, G. Börsch: One-week low dose triple therapy for cure of Helicobacter pylori infection. Europ. J. Gastroenterol. Hepatol. 7 (1995), 9-11.
11. Mégraud, F.: H.pylori resistance to antibiotics. In Hunt, R. H., G. N. J. Tytgat (Ed.): Helicobacter pylori. Basic Mechanisms to Clinical Cure (Kluwer Academic Publishers: Dordrecht 1994), 570-583.
12. Moayyedi, P., D. S. Tomkins, A. T. R. Axon: Determination of the optimum dose of omeprazole in a new triple therapy regimen for eradicating Helicobacter pylori. Gut 35, Suppl. 5 (1994), S 16.
13. Penston, J. G.: Helicobacter pylori eradication - understandable caution but no excuse for inertia. Aliment. Pharmacol. Ther. 8 (1994), 369-389.
14. Sung, J. Y., S. C. S. Chung, T. K. W. Ling, M. Y. Yung, V. K. S. Leung, E. K. W. No, M. K. K. Li, A. F. B. Cheng, A. K. C. Li: Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. New Engl. J. Med. 332 (1995), 139-142.
15. Tytgat, G. N. J.: Review article. Treatments that impact favourable upon the eradication of Helicobacter pylori and ulcer recurrence. Aliment. Pharmacol. Ther. 8 (1994), 359-368.
16. Yamada, T., D. Ahnen, D. H. Alpers, H. B. Greenberg, L. Gray, K. B. Joscelyn, G. Kauffman, D. K. Podolsky, W. A. Ray, D. Schaberg, F. E. Silverstein, M. V. Sivak, A. L. B. Williams, R. Yolken: Helicobacter pylori in peptic ulcer disease. J. Amer. med. Ass. 272 (1994), 65-69.